Leman Biotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 12

Leman Biotech General Information

Description

Developer of immunotherapies for metabolic cancer designed to treat solid tumors. The company utilizes immunometabolic reprogramming and artificial intelligence to develop metabolic enhanced car-t cells, IL-10-Fc fusion proteins, tumor-infiltrating lymphocytes, interleukin-10 mutants, biological macromolecular drugs, and immune cell drugs, thereby enabling healthcare providers to improve immune cell function and enhance therapeutic responsiveness in oncology applications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Futian International Biomedical Industrial Park
  • Number 1 Haihong Road, Futian District
  • Shenzhen, Guangdong
  • China
+86 173
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Futian International Biomedical Industrial Park
  • Number 1 Haihong Road, Futian District
  • Shenzhen, Guangdong
  • China
+86 173

Leman Biotech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leman Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC 07-Jul-2026 Completed Generating Revenue
9. Early Stage VC (Series A) 04-Mar-2026 Completed Generating Revenue
8. Early Stage VC 28-Feb-2026 Completed Generating Revenue
7. Early Stage VC 27-Apr-2025 Completed Generating Revenue
6. Secondary Transaction - Private 27-Apr-2025 Completed Generating Revenue
5. Early Stage VC (Series A) 12-Nov-2024 Completed Generating Revenue
4. Early Stage VC 29-May-2024 Completed Generating Revenue
3. Grant 19-Apr-2024 Completed Generating Revenue
2. Secondary Transaction - Private 31-Oct-2022 $15.7M Completed Generating Revenue
1. Seed Round 18-Jan-2022 $15.7M $15.7M Completed Startup
To view Leman Biotech’s complete valuation and funding history, request access »

Leman Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapies for metabolic cancer designed to treat solid tumors. The company utilizes immunometabolic r
Drug Discovery
Shenzhen, China

Shanghai, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Leman Biotech Competitors (1)

One of Leman Biotech’s competitors is JW Therapeutics, a Formerly VC-backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
JW Therapeutics Formerly VC-backed Shanghai, China
You’re viewing 1 of 1 competitors. Get the full list »

Leman Biotech Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Guofang Private Equity Fund Management Growth/Expansion Minority
Guangdong Yuecai Zhongyin Private Equity Investment Fund Management PE/Buyout Minority
Guangdong Yuecai Venture Capital Growth/Expansion Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
Zhongshan Financial Investment Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Leman Biotech FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process